In line with this, Ming et al. [164] showed that ROS levels measured by fluorometry were significantly enhanced in peripheral blood lymphocytes from both sporadic PD patients and those with the PARK2 C441R mutation compared to healthy controls. This evidence concerns the gene PRKN and Parkinson disease.